BDNF and epilepsy: Therefore, Rhy may downregulate the BDNF pathway under some conditions of neuronal activation such as epilepsy or after ketamine administration, while it may upregulate it in specific pathological conditions such as stroke, stress or Tourette syndrome (Table 1).